Skip to main content
Premium Trial:

Request an Annual Quote

Even Rose-Colored Glasses Don't Help This Picture

If you're prone to pessimism, you might want to skip to the next post. The Wall Street Journal's reporting that "the financial crunch is shaking the foundation of the global biotech industry, threatening to slow the development of new medicines and cut high-tech jobs in the U.S. and Europe." According to the article, industry watchers expect small biotechs to lay off staff, stop clinical trials, or declare bankruptcy as they attempt to weather the storm. This would also weaken the pharma industry that has come to rely on compounds developed by biotechs. The article adds:

In the U.S., 38% of 370 small biotech companies are operating with less than a year's worth of cash, and nearly 100 publicly traded biotech companies have less than six months' cash, according to the Biotechnology Industry Organization in Washington.

 

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.